Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase

Circulation Research

Volumn 89, Issue 8, 2001, Pages 684-691

  Soriano, Francisco Garcia ^a   Pacher, Pál ^a   Mabley, Jon ^a   Liaudet, Lucas ^a   Szabó, Csaba ^a  

^a INOTEK CORPORATION   (United States)

Author keywords

Apoptosis; Diabetes; Endothelium; Necrosis; Nitric oxide

Indexed keywords

ADENOSINE TRIPHOSPHATE; FREE RADICAL; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DNA STRAND BREAKAGE; ENZYME ACTIVATION; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

EID: 0035851210     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh2001.097797     Document Type: Article

References (46)

1. Diabetic endothelial dysfunction: The role of poly (ADP-ribose) polymerase activation
2. Endothelial dysfunction in a rat model of endotoxic shock: Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite
3. High-performance liquid chromatography analysis of oxidized and reduced pyridine dinucleotides in specific brain regions
4. Protection against hemorrhagic shock in mice genetically deficient in poly (ADP-ribose) polymerase
5. Loss of the MYC gene amplified in human HL-60 cells after treatment with inhibitors of poly(ADP-ribose) polymerase or with dimethyl sulfoxide
6. Resistance to endotoxic shock as a consequence of defective NF-B activation in poly (ADP-ribose) polymerase-1 deficient mice
7. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NFB activation
8. Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury
9. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase
10. Increased adhesion of neutrophils to retinal vascular endothelial cells exposed to hyperosmo larity
11. Activation of nuclear factor-B in cultured endothelial cells by increased glucose concentration: Prevention by calphostin C
12. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion
13. Ultrastructural changes and immunohistochemical localization of nitric oxide synthase, advanced glycation end products and NF-κB in aorta of streptozotocin treated Mongolian gerbils
14. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes
15. Generation of reactive oxygen intermediates, activation of NF-B, and induction of apoptosis in human endothelial cells by glucose: Role of NO synthase?
16. Poly(ADP-ribose) in the cellular response to DNA damage
17. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite
18. Endo thelial dysfunction in a rat model of endotoxic shock: Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite
19. Role of oxidative metabolism on endothelium-dependent vascular relaxation of isolated vessels
20. Effects of metabolic inhibitors on endothelium-dependent and endothelium-independent vasodilatation of rat and rabbit aorta
21. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
22. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells
23. The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsorcd by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society
24. Vascular superoxide production by NAD(P)H oxidasc: Association with endothelial dysfunction and clinical risk factors
25. Interference of glycosylated human hemoglobin with endothelium-dependent responses
26. +, free radicals, and vascular dysfunction in early diabetes mellitus
27. Time course of changes in endothelium-dependent and -independent relaxation of chronically diabetic aorta: Role of reactive oxygen species
28. Vascular function in type 2 diabetes mellitus and pre-diabetes: The case for intrinsic endotheiopathy
29. Reducing the burden of diabetes: Managing cardiovascular disease
30. Increased superoxide anion formation in endothelial cells during hyperglycemia: An adaptive response or initial step of vascular dysfunction?
31. Cancer cell selectivity of 5-iodo-6-aminobenzopyrone (INH2BP) and methyl-3,5-diiodo-4(4′-methoxyphenoxy) benzoate (DIME)
32. Resistance-modifying agents, 9: Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase
33. 2 cytotoxicity by inhibiting poly(ADP-ribose) polymerase
34. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase
35. A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI)
36. Coronary artery responses to physiological stimuli are improved by deferoxamine but not by -arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors
37. Evidence for poly(ADP-ribose) polymerase activation in the diabetic retina
38. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension
39. Oxygen free-radical scavengers and immune destruction of murine islets in allograft rejection and multiple low-dose streptozocin-induced insulitis
40. Protection by 3-aminobenzamide and nicotinamide against streptozotocin-induced beta-cell toxicity in vivo and in vitro
41. Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis
42. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic β-cell destruction and diabetes development induced by streptozocin
43. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes
44. Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes
45. Inhibition of poly (ADP-ribose) synthetase either by gene disruption or by enzyme inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes and islets of Langerhans from cytokine-mediated dysfunction